Related Experiment Videos
Chronic fatigue syndrome: a risk factor for osteopenia?
Jo Nijs1, Kenny De Meirleir, Patrick Englebienne
1Department of Human Physiology, Faculty of Physical Education and Physiotherapy, Vrije Universiteit Brussel, Brussel, Belgium. Jo.Nijs@vub.ac.be
Medical Hypotheses
|November 27, 2002
Summary
Chronic fatigue syndrome (CFS) may deplete bone mineral density through increased calcium re-absorption and enhanced bone resorption. Decreased insulin-like growth factor I (IGF-I) further contributes to bone loss in CFS patients.
Area of Science:
- Immunology
- Bone Biology
- Metabolic Disorders
Background:
- No current data link chronic fatigue syndrome (CFS) to bone mineral density (BMD) depletion.
- Pathophysiological changes in CFS may negatively impact bone health.
Purpose of the Study:
- To investigate the potential mechanisms by which CFS may lead to bone mineral density depletion.
- To explore the role of antiviral pathways, Mycoplasma fermentans, and IGF-I in CFS-associated bone loss.
Main Methods:
- Review of existing pathophysiological observations in CFS patients.
- Analysis of the proposed mechanisms involving calcium homeostasis, macrophage activation, and osteoblast proliferation.
Main Results:
- Deregulation of the 2,5A synthetase RNase L pathway may increase calcium re-absorption.
- Mycoplasma fermentans-derived MALP-2 can enhance bone resorption via prostaglandin stimulation.
- Decreased IGF-I levels may impair osteoblast proliferation, favoring bone resorption.
Conclusions:
- CFS pathophysiological mechanisms suggest a potential for bone mineral density depletion.
- Further research is warranted to confirm and quantify bone loss in CFS patients.